Follow Flash Finance FollowTelegram
43tech score
/ 100

Kwality Pharma (KPL) — Technical Setup

₹3,515.90 +1.17%   Range Normal Volatility Neutral

As of 2026-11-02 close Sector: Pharma Pharmaceuticals All technical setups →

Summary

Kwality Pharma is in a range on the daily chart. RSI(14) is 49.6, MACD is below its signal line, ADX reads 15 (weak trend). Volume in the latest session was 0.5× its 20-day average. Over three months it has outperformed the Nifty 50 by 40.2 percentage points. Nearest support is ₹3,470.00 and resistance ₹3,783.90. Its technical score is 43/100 (neutral).

Trend (daily)
Bullish
Trend (weekly)
—
Trend (monthly)
—
RSI (14)
49.56
MACD
Bearish
ADX (14)
15.11
Volume vs 20d avg
0.49×
Support
₹3,470.00 (−1.3%)
Resistance
₹3,783.90 (+7.6%)
RS vs Nifty (3M)
+40.20%
RS rating
95.00

🧮 How the 43/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend7/20
  • Close above 20-day EMA (-0.63)0/3
  • 20-day EMA above 50-day EMA3/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (15.11)1/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum10/20
  • RSI(14) in the bullish zone (55-70 best) (49.56)2/6
  • MACD line above its signal line0/4
  • MACD line above zero (15.29)3/3
  • 12-day rate of change positive (3.59)3/3
  • Stochastic %K above %D0/2
  • Outperforming the Nifty 50 over 3 months (40.20)2/2
Volume5/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (0.06)5/5
  • More volume on up days than down days (20 sessions) (0.83)0/5
  • Close above 20-day VWAP (-0.13)0/5
Volatility11/20
  • Daily range (ATR%) contained — ≤2.5% scores full (5.18)2/6
  • Price in the upper half of its Bollinger Bands (0.45)2/5
  • Shallow drawdown from the 52-week high (-10.97)3/5
  • Volatility contracting (20-day volatility below its 6-month median) (15.80)4/4
Support / Resistance10/20
  • Room to the next resistance (≥8% scores full) (7.62)3/5
  • Support close below (a tight, definable stop) (1.31)5/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-10.97)2/5

🧭 Regime: Range

Normal Volatility — Bollinger width is in the 22th percentile of the last six months.

Suits: Mean reversion / range trading. No directional edge: buy near range support, sell near resistance, and treat breakouts with suspicion until volume confirms them.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the Bollinger Band Reversion rules for KPL — close below the lower bollinger band (20,2) while above the 200-day sma.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly———
Weekly———
Daily▲ Bullish49.56-0.21

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.

📶 Volume & VWAP

Relative volume
0.49×
5d / 20d volume
0.80×
Volume ROC (10d)
+19.30%
Up/down volume
0.83×
OBV (20d)
Falling / flat
Chaikin MF (20)
0.06
VWAP 20d
₹3,520.42 (-0.13%)
VWAP 50d
₹3,535.01 (-0.54%)
Anchored VWAP · 52W low
₹2,879.68 (+22.09%)
Anchored VWAP · 52W high
₹3,600.80 (-2.36%)
Anchored VWAP · YTD
₹2,877.73 (+22.18%)
Avg turnover (20d)
₹10 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks.

💪 Relative strength

vs Nifty 1M
-7.07%
vs Nifty 3M
+40.20%
vs Nifty 6M
+124.91%
vs Nifty 1Y
—
RS rating
95.00
Mansfield RS
—
vs Pharma index 3M
+34.18%
vs sector peers 3M
+36.70%

KPL ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹3,949.00+12.3%1
Resistance₹3,783.90+7.6%3
Close₹3,515.90—
Support₹3,470.00−1.3%1
Support₹3,211.10−8.7%3
Support₹2,859.90−18.7%3
Support₹2,511.50−28.6%3

52-week range: ₹1,561.00 – ₹3,949.00 (-10.97% from the high).

🌀 Fibonacci

Measuring the up-swing from ₹1,581.00 (2026-05-04) to ₹3,949.00 (2026-09-21). Price has retraced 18.3% of it.

RatioPriceDistance
23.6% retracement₹3,390.15-3.6% nearest
38.2% retracement₹3,044.42-13.4%
50.0% retracement₹2,765.00-21.4%
61.8% retracement₹2,485.58-29.3%S/R confluence
78.6% retracement₹2,087.75-40.6%
127.2% extension₹4,593.10+30.6%
161.8% extension₹5,412.42+53.9%
200.0% extension₹6,317.00+79.7%

🕯️ Candlesticks (last 5 sessions)

  • Doji 2026-10-29 neutral Weak · 20

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
DIVISLABDivi's Laboratories Limited ₹9,945.50 +1.69% 94 Uptrend 92.00
ACUTAASAcutaas Chemicals Limited ₹3,892.60 -2.77% 87 Uptrend 96.00
SMSPHARMASMS Pharmaceuticals Limited ₹504.15 -1.41% 87 Strong Uptrend 92.00
CORONACORONA Remedies Limited ₹2,171.10 +1.00% 86 Uptrend 84.00
ZYDUSLIFEZydus Lifesciences Limited ₹1,240.50 -0.40% 85 Uptrend 85.00
PPLPHARMAPiramal Pharma Limited ₹239.92 +0.42% 83 Strong Uptrend 90.00
DRREDDYDr. Reddy's Laboratories Limited ₹1,342.00 -0.74% 82 Strong Uptrend 76.00
AARTIDRUGSAarti Drugs Limited ₹453.80 +4.27% 81 Strong Uptrend 77.00
ALIVUSAlivus Life Sciences Limited ₹1,447.60 +2.28% 81 Strong Uptrend 92.00
GLANDGland Pharma Limited ₹3,066.60 -0.95% 80 Uptrend 94.00
🔗 More on KPL

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI